GLP-1 Weight Loss in Cleveland (2026)
133 GLP-1 telehealth providers ship to Cleveland, Ohio. Compounded semaglutide averages $189/month — same active ingredient as Wegovy and Ozempic, a fraction of the cost.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Editor's picks · Cleveland
Best GLP-1 providers serving Cleveland
No insurance needed
vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
- Top pick8.6Get started →Save $1,300/mo vs Wegovy
Compounded from
$49/mo
- 8.5Get started →Save $1,250/mo vs Wegovy
Compounded from
$99/mo
- 8.1Get started →Save $1,250/mo vs Wegovy
Compounded from
$99/mo
- 7.9Get started →Save $1,250/mo vs Wegovy
Compounded from
$99/mo
- 7.8Get started →Save $937/mo vs Zepbound
Compounded from
$149/mo
- 7.7Get started →Save $1,250/mo vs Wegovy
Compounded from
$99/mo
| Provider | Compounded from | Save vs brand | |
|---|---|---|---|
8.6Enhance MDTop pick | $49/mo | Save $1,300/mo | Get started → |
8.5Embody | $99/mo | Save $1,250/mo | Get started → |
8.1Strut Health | $99/mo | Save $1,250/mo | Get started → |
7.9Live Vital | $99/mo | Save $1,250/mo | Get started → |
7.8Gala | $149/mo | Save $937/mo | Get started → |
7.7Trimi Health | $99/mo | Save $1,250/mo | Get started → |
About GLP-1 Access in Cleveland
Cleveland is a major city in northeastern Ohio, located in Ohio with a population of approximately 373,000. Telehealth is legal in Ohio, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Cleveland ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.
Ohio's adult obesity rate is approximately 36.9% based on CDC Behavioral Risk Factor Surveillance System data[2], and state rankings are published in CDC's Adult Obesity Facts[3].
Browse by Medication
All GLP-1 Providers Serving Cleveland
Enhance MD
Verified partnerBest for: lab-monitored compounded GLP-1 with mandatory video visit
Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician — a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus aggressive intro pricing ($49 first month on Core).
Score Breakdown
Pros
- ✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
- ✓Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
- ✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
- ✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
- ✓Low first-month intro pricing: $49 Core, $99 Advanced, $189 Elite
- ✓Unlimited clinician messaging and dose-adjustment support included
Cons
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
- ✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
- ✗No insurance accepted — cash pay, HSA/FSA eligible
- ✗Intro pricing resets to full tier rate after 30 days — the $49/$99/$189 figures aren't ongoing cost
Embody
Verified partnerBest for: lowest first-month entry pricing on compounded GLP-1s
Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation. Aggressive first-month entry pricing with all 50 states and a 24/7 clinician messaging model led by a board-certified internal medicine CMO.
Score Breakdown
Pros
- ✓Lowest first-month entry pricing in the compounded segment ($99 first month for semaglutide, $149 for tirzepatide injection)
- ✓Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
- ✓Available in all 50 states with no insurance friction
- ✓24/7 unlimited clinician messaging and dose-adjustment support included
- ✓Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine
Cons
- ✗Refill pricing jumps to $299/month after the first month — initial $99/$149 is an intro rate, not the ongoing cost
- ✗Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
- ✗Pharmacy partners not publicly named — compounding source transparency is limited
- ✗Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Strut Health
Verified partnerBest for: oral-lozenge compounded GLP-1 access
Strut Health offers LegitScript + ACHC-accredited compounded semaglutide and tirzepatide in both injectable and oral lozenge formats, shipping to 49 states. Board-certified US physicians handle prescribing with free unlimited follow-up messaging, but eligibility is gated behind a 'medical necessity' clinician determination that isn't publicly defined.
Score Breakdown
Pros
- ✓Both LegitScript and ACHC accredited — pharmacy oversight most compounded GLP-1 providers don't carry
- ✓Oral lozenge option for semaglutide ($99/mo) and tirzepatide ($199/mo) — an injection-free alternative
- ✓Auto-refill pricing saves 13–21% vs one-off orders
- ✓Free unlimited follow-up messaging with board-certified US physicians
- ✓Ships to 49 states (only Arkansas excluded)
Cons
- ✗Requires a "medical necessity" review, but the criteria aren't published — you can't self-screen before paying for a consult
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Pharmacy partners aren't named — you can't verify the compounding source
- ✗No insurance accepted — cash pay only
- ✗Phone consultation requirement varies by state
Live Vital
Verified partnerBest for: shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options
Live Vital is a physician-led telehealth practice founded by Dr. Patrick Taylor, MD, offering compounded GLP-1 weight loss — semaglutide from $99/mo and tirzepatide from $183/mo, billed as 3-month programs — alongside peptide and hormone therapy. Every plan is doctor-prescribed, filled by a licensed US pharmacy, and shipped to your door, with unlimited care-team messaging and no lock-in. Fully telehealth in all 50 states.
Score Breakdown
Pros
- ✓Physician-led — founded by Dr. Patrick Taylor, MD; all treatments doctor-prescribed via the clinical team
- ✓Transparent published pricing: semaglutide from $99/mo, tirzepatide from $183/mo (billed as 3-month programs)
- ✓Every plan includes doctor prescribing, licensed-pharmacy medication, and direct-to-door shipping
- ✓Unlimited messaging with the care team; cancel or pause anytime with no lock-in
- ✓Fully telehealth in all 50 states
Cons
- ✗Sold as 3-month programs (semaglutide $299 / tirzepatide $549 per quarter); 'starting at' rates can rise with dose
- ✗Doesn't accept insurance (HSA/FSA funds only)
- ✗Compounding pharmacy isn't named (only 'a licensed US pharmacy')
- ✗Also a peptide/longevity practice; those peptides are not FDA-approved (the site discloses this)
Gala
Verified partnerBest for: compounded GLP-1/GIP combo therapy on a yearly subscription with free shipping nationwide
Gala (legal entity AI Coaching Inc., d/b/a Gala GLP-1) is a Delaware-incorporated telehealth platform offering compounded semaglutide and compounded tirzepatide on a yearly subscription, a lower-priced microdosing program, and brand-name Ozempic. The marketing site claims licensed providers in all 50 states with free shipping included. An oral Wegovy pill option is listed as 'coming soon.'
Score Breakdown
Pros
- ✓Compounded semaglutide and tirzepatide at $179/mo with all doses included on the yearly plan
- ✓Lower microdosing tirzepatide tier at $149/mo for a sub-therapeutic starting protocol
- ✓Brand-name Ozempic available alongside compounded options
- ✓Claims licensed providers in all 50 states with free shipping included
- ✓24/7 support, provider visit included, cancel anytime
- ✓LegitScript verified
Cons
- ✗$179/mo requires a yearly subscription — the standalone monthly price isn't published
- ✗Brand-name Ozempic at $1,299/mo is higher than peers (e.g., Found at $1,100/mo)
- ✗Pharmacy partners not named — only a "network of pharmacies" reference
- ✗Wegovy oral pill listed as "coming soon," not yet available
- ✗Per-state availability isn't listed; the all-50-states claim is gated behind intake
In-Person vs Telehealth in Cleveland
Patients in Cleveland have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to Ohio addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in Ohio varies by plan[4].
Cost of GLP-1 Medications in Cleveland
Brand-name Wegovy in Cleveland typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $$189/month in Ohio, representing savings of more than $13,000 per year.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Get Cleveland Price Alerts
Be the first to know about new GLP-1 providers and price changes in Cleveland.
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
- 3.CDC — State Obesity Rankings and Adult Obesity Facts— Centers for Disease Control and Prevention.
- 4.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.